No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305.

No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305.

<h4>Introduction</h4>Tenofovir (TDF)-containing PrEP is effective for HIV prevention, but its effect on health-related quality of life (QOL) is unknown. Using data from HPTN 069/ACTG A5305, a randomized study of potential PrEP regimens comparing maraviroc alone, or together with TDF or e...

Full description

Bibliographic Details
Main Authors: Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, Timothy J Wilkin, K Rivet Amico, Raphael J Landovitz, Adriana Andrade, Ying Q Chen, Wairimu Chege, Marybeth McCauley, Roy M Gulick, Bruce R Schackman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0206577

Internet

https://doi.org/10.1371/journal.pone.0206577

Similar Items